-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane CAS 98737-29-2 Darunavir Intermedia High Munditia
| Nomen chemicum | (2S,3S)-1,2-Epoxy-3-(Boc-Amino) -4-Phenylbutane |
| Synonyma | (Boc-Amino) -1,2-Epoxy-4-Phenylbutane;(2S,3S) -3-(tert-Butoxycarbonylamino) -1,2-epoxy-4-phenylbutane;Darunavir medium |
| CAS Number | 98737-29-2 |
| CATTUS Number | RF-PI286 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C15H21NO3 |
| M. Pondus | 263.33 |
| Solubilitas | Insolubilis in aqua.Solutum in Methanol, Chloroforme |
| Shipping Condition | Uit sub Ambient Temperature |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba ad Off-White Crystalline pulveris |
| Lepidium sativum (HPLC) | Lepidium sativum confirmatur HPLC |
| Liquescens punctum | 123.0~ 128.0℃ |
| Humor (KF) | ≤0.50% |
| Residere in Ignition | ≤0.20% |
| Puritas / Analysis Methodus | ≥99.0% (HPLC) |
| Chlorohydrin (HPLC) | ≤0.20% |
| Chloromethyl Ketone | ≤0.10% |
| Alia immunitas | ≤0.20% |
| Totalis immunditias | ≤1.0% |
| Chiral immunditia | ≤0.30% |
| Metalla gravis | ≤20ppm |
| Test Standard | Enterprise Standard |
| Consuetudinem | Darunavir (CAS 206361-99-1) HIV-1 Protease Inhibitor |
sarcina: Utrem, aluminium foil, pera, cardboard Drum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum (2S,3S) -1,2-Epoxy-3-(Boc-Amino) -4-Phenylbutane (CAS: 98737-29-2) magna qualitate intermedium typice in synthesi Darunavir (CAS 206361-99-1) et Darunavir Ethanolate (CAS 635728-49-3).
Darunavir (CAS 206361-99-1) est novum genus peptidis anti retroviralis inhibitores in AIDS therapia.Primum a Johnson pharmaceutica Islandiae ramo, Tibotec evoluta est.Est summae bioavailability in 6 protease inhibitores (saquinavir, ritonavirvir, indinavir, naphthalene nelfinavir, amprenavir et ABT378/r).Agit claudendo formationem novarum ac maturarum virium particularum e superficie cellarum hospitii infectae et tutelam viri inhibendo.Cum productum diu adhibitum est, plerumque HIV vectorem in sanguinem reducere potest, comitem CD4 cellularum augere, casum infectio HIV minuere, qualitatem vitae prorogare et vitam augere.Adultis qui HIV viro infectis convenit, sed usum medicamentorum antiretroviralium exsistentium nullum effectum habent.Medicamentum componi debet cum usu bibulae ritonavirorum vel aliorum antiretroviralium humilium ad efficaciam emendandam.
